The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 5th Edition

Oct 10, 2012
245 Pages - Pub ID: KLI4886527
Share this report
Attention: There is an updated edition available for this report.
 
Online Download $3,995
Departmental Site License (one location, up to 10 users) $5,995
Global Site License $7,990
This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition:
  • Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)
  • Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
  • Parenteral Nutrition
For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population. Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets. The market segments provide an overview, description of products on the market, new developments, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

Coverage of Issues and Trends in Clinical Nutrition 

There are several issues and trends that are impacting the clinical nutrition market, including:
  • Wound Care Applications
  • Reimbursement of Nutrition Products
  • Food Programs Adjusted Numbers for Recession
  • Disease Statistics
  • Nursing Home and Hospice Trends
  • Nutrition and Education
  • DHA and ANA Additives
  • Counterfeit Infant Formulas
  • Infant Formula Recalls
  • Acquisition, Mergers and Alliances
  • Enteral Feeding Pumps
A Growing Market with Thriving Competition

Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. The majority of competitive participation is in developed regions such as the United States, Western Europe, and Japan. However, many companies are expanding into less developed regions, intensifying competition in less tapped markets. China, for example, is among the expanding competitive regions as companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:
  • Abbott
  • Baxter
  • B Braun
  • Danone
  • Fresenius Kabi
  • Hospira
  • Mead Johnson
  • Nestle
  • Perrigo Company
  • Pfizer
Revenues for each segment were generated using dollar and unit sales for each product.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 70 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2006 through 2011, with forecast data provided for 2012 through 2016. Compound annual growth rates (CAGRs) are provided for the 2006-2011, 2010-2016 and 2006-2016 periods for each industry segment covered. Competitive analysis is provided for the year 2011. The forecasted market analysis for 2011-2016 was based on demographic trends, new developments, and global expansion.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please consult with your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Infant Nutrition
Enteral Nutrition
Parenteral Nutrition
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting the Market
Leading Competitors
CHAPTER TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY
Introduction and History of Nutrition in the Clinical Setting
Defining Clinical Nutrition
Infant Nutrition
Enteral Nutrition
Parenteral Nutrition
Regulatory Environment
Environments for Clinical Nutrition
Hospital Settings
United States
International
Skilled Nursing Settings
United States
International
Home Care Settings
Hospice
Essential Nutrients
Carbohydrates
Proteins
Fats
Vitamins
Minerals
Demographics and Statistics
Worldwide Demographics
Global Aging Population
U.S. Demographics
U.S. Aging Population
Cancer and Nutrition
Cardiovascular Disease and Nutrition
Diabetes and Nutrition
HIV/AIDS and Nutrition
Obesity and Nutrition
Summary of Diseases
CHAPTER THREE: INFANT NUTRITION
Overview
Product Categories
Milk-based Formulas
Soy-based Formulas
Elemental Formulas
Follow-Up Formulas
Organic Infant Formula
Probiotic/Prebiotic Infant Formula
Premature Infant Formulas
Newborn Formulas
Other Specialized Formulas
Research & Development Trends
Market Size and Growth
Global Market Introduction
Sales by Product Type
Global Markets
Competitive Analysis
CHAPTER FOUR: ENTERAL NUTRITION
Overview
Product Categories
Industry Developments
Current Developments
Recent Business Activities
New Product Launches
Market Size and Growth
Global Market Introduction
Sales by Product Type
Global Markets
Competitive Analysis
CHAPTER FIVE: PARENTERAL NUTRITION
Overview
Product Categories
Amino Acids
Dextrose
Fats
Nutritional Additives
Industry Developments
Market Size and Growth
Global Market Introduction
Sales by Product Type
Global Markets
Competitive Analysis
CHAPTER SIX: TOTAL MARKET SIZE AND FORECAST
Total Market Size and Forecast
Global Market Overview
Sales by Broad Market Segment
Markets by Geographic Region
Competitor Analysis
CHAPTER SEVEN: ISSUES AND TRENDS AFFECTING
THE NUTRITION MARKET
Introduction
Wound Care applications
Parenteral Nutrition Shortages
Infant Formulas or Breast Milk: A Controversial Topic
Breast Feeding Rates in the U.S.
WHO
Manufacturer Marketing of Infant Formula
Reimbursement of Nutrition Products
Food Programs
WIC
WIC Contracts
Other Programs for Infant Formula Reimbursement
Cost Containment
Nutrition and Education
The Registered Dietician
Dietician Statistics in the United States
DHA and ARA Additives
Counterfeit Infant Formulas
Recalls for Infant Formulas
Industry Acquisitions, Mergers and Alliances
Enteral Feeding Pumps
Abbott Laboratories
Caesarea Medical Electronics
Covidien/Kendall
Fresenius Kabi
Nestle Nutrition
Moog, Inc.
CHAPTER EIGHT: CORPORATE PROFILES
Introduction
Abbott
Baxter
B Braun
Danone
Fresenius Kabi
Hospira
Mead Johnson Nutrition
Nestlé
Perrigo
Pfizer
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1
The Global Market for Clinical Nutrition, 2008-2016
Figure 1-1
The Global Market for Clinical Nutrition 2008-2016
CHAPTER TWO: INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY
Table 2-1
Nutrient Requirements for Infant Formulas as Required by the FDA Infant Formula Act
Table 2-2
U.S. Registered Hospitals by Type, 2010
Figure 2-1
Number of Hospitals in the US, 1975-2005, Estimated 2015
Table 2-3
Statistics for U.S. Hospitals, 2010
Table 2-4
U.S. Hospital Length of Stay, Average by Age Group
Table 2-5
Registered Hospitals and Acute Care Centers by Country
Figure 2-2
Number of Nursing Homes, 2000-2010
Table 2-6
Estimated Nursing Service Establishments and Care Centers by Country
Figure 2-3
Number of Home Care Agencies in the U.S., 1980-2009
Figure 2-4
Growth in Hospice Programs in the United States, 1998-2009
Figure 2-5
Patients Served with Hospice Programs in the United States, 1998-2009
Table 2-7
Percentage of Hospice Admissions by Primary Diagnosis, 2005 -2009
Table 2-8
Hospice Cases by Diagnosis, 2010 Estimates
Table 2-9
Essential Nutrients for Human Health
Table 2-10
World Population by Selected Geographical Region, 2010 - 2050
Figure 2-6
World Population by Selected Geographical Region, 2010–2050
Table 2-11
Percent Population Over 65 by Year and Region, 2010-2050
Table 2-12
International Population Trend Age 65+
Figure 2-7
International Population Trend Age 65+
Figure 2-8
Estimated World Population by Age, 2010 and 2050
Table 2-13
The U.S. Population, 1980-2050
Figure 2-9
The U.S. Population, 1980-2050
Table 2-14
United States Population Trend Age 65+
Figure 2-10
United States Population Trend Age 65+
Table 2-15
World Cancer Incidence by Selected Types of Cancer, 2010 and 2020, all races, both sexes
Figure 2-11
Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020
Table 2-16
Total Cancer Incidence by Sex and Country, 2010 Estimates
Figure 2-12
Total Cancer Incidence by Sex and Country, 2010 Estimates
Table 2-17
Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cancer
Table 2-18
Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cardiovascular Diseases
Table 2-19
Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Type 2 Diabetes
Table 2-20
Total Number of People Living with HIV/AIDS, Newly Infected Population and Deaths, 2010 by Region
Figure 2-13
The Role of Nutrition Education as HIV Infection Develops
Table 2-21
Estimated Obesity by Country, 2009 Estimates
Figure 2-14
Estimated Obesity by Country as a Portion of Total Population 2009 Estimates
Figure 2-15
Increases in Obesity by Country—2007 and 2009 Figures
Table 2-22
Summary of Strength of Evidence on Factors that Might Promote or Protect Against Weight Gain and Obesity
Table 2-23
Classification of Overweight in Adults According to BMI
Table 2-24
Prevalence/Incidence of Diseases by Type, 2010 Estimates
Figure 2-16
Prevalence/Incidence of Disease by Type, 2010 Estimates
Figure 2-17
Prevalence/Incidence of Disease by Type, 2010 Estimates
Table 2-25
Disease Mortality by Type, 2010 Estimates
Figure 2-18
Disease Mortality by Type, 2010 Estimates
Figure 2-19
Disease Mortality by Type, 2010 Estimates
CHAPTER THREE: INFANT NUTRITION
Table 3-1
Composition of Breast Milk (early and mature range) and Select Infant Formulas
Table 3-2
Live Births and Birth Rates by Country*
Figure 3-1
Live Births by Country
Figure 3-2
Births Rates by Country
Figure 3-3
Children Under 5 Years
Table 3-3
Marketed Infant Formulas (Manufacturer, Product Types, and Product Lines)
Table 3-4
The Market for Infant Nutrition 2008-2016
Figure 3-4
The Global Market for Infant Nutrition 2008-2016
Table 3-5
The Global Market for Infant Nutrition by Product Type 2012
Figure 3-5
The Global Market for Infant Nutrition by Product Type 2012
Table 3-6
The Global Market for Infant Nutrition Estimated Products Sales by Select Geographic Region, 2012
Figure 3-6
The Global Market for Infant Nutrition Market Share by Select Geographic Region,2012
Table 3-7
The Global Market for Infant Nutrition Estimated Revenues and Market Share of Leading Suppliers, 2012
Figure 3-7
The Global Market for Infant Nutrition Estimated Market Share by Leading Suppliers 2012
Table 3-8
The Global Market for Infant Nutrition Estimated Market Shares by Region for Leading Suppliers 2012
Figure 3-8
Estimated Infant Formula U.S. Market Shares for Leading Suppliers 2012
Figure 3-9
Estimated Infant Formula Market Shares Outside the U.S. for Leading Suppliers 2012
CHAPTER FOUR: ENTERAL NUTRITION
Table 4-1
Aging Population, Percent of Total Population, and Annual Growth by Country, 2012
Figure 4-1
Over 65 Population by Country
Figure 4-2
Over 65 Population as a Percent of Total Population by Country, 2012
Figure 4-3
Over 65 Annual Population Growth by Country
Table 4-2
Marketed Pediatric and Adult Enteral Formulas (Manufacturer, Product Types, and Product Lines)
Table 4-3
The Market for Enteral Nutrition 2008-2016
Figure 4-4
The Global Market for Enteral Nutrition 2008-2016
Table 4-4
The Global Market for Enteral Nutrition by Product Type, 2012
Figure 4-5
The Global Market for Enteral Nutrition by Product Type, 2012
Table 4-5
The Global Market for Enteral Nutrition Estimated Products Sales by Select Geographic Region, 2012
Figure 4-6
The Global Market for Enteral Nutrition Market Share by Geographic Region, 2012
Table 4-6
The Global Market for Enteral Nutrition Estimated Revenues and Market Share of Leading Suppliers, 2012
Figure 4-7
The Global Market for Enteral Nutrition Estimated Market Share by Leading Suppliers,2012
Table 4-7
The Global Market for Enteral Nutrition Estimated Market Shares by Region for Leading Suppliers, 2012
Figure 4-8
The Global Market for Enteral Nutrition Estimated U.S. Market Shares for Leading Suppliers, 2012
Figure 4-9
The Global Market for Enteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers, 2012
CHAPTER FIVE: PARENTERAL NUTRITION
Table 5-1
Aging Population, Percent of Total Population, and Annual Growth by Country*, 2012
Figure 5-1
Over 65 Population by Country
Figure 5-2
Over 65 Population as a Percent of Total Population by Country, 2012
Figure 5-3
Over 65 Annual Population Growth by Country
Table 5-2
Standard Electrolyte Requirements
Table 5-3
Standard Parenteral Multivitamin Package* Vitamin
Table 5-4
Standard Parenteral Trace Elements Package
Table 5-5
Single Parenteral Trace Element Formulations
Table 5-6
Major Marketed Parenteral Formulas (Manufacturer, Product Types, and Product Lines)
Table 5-7
The Market for Parenteral Nutrition 2008-2016
Figure 5-4
The Global Market for Parenteral Nutrition 2008-2016
Table 5-8
The Global Market for Parenteral Nutrition by Product Type* 2012
Figure 5-5
The Global Market for Parenteral Nutrition by Product Type* 2012
Table 5-9
The Global Market for Parenteral Nutrition Estimated Products Sales by Select Geographic Region, 2012
Figure 5-6
The Global Market for Parenteral Nutrition Market Share by Select Geographic Region,2012
Table 5-10
The Global Market for Parenteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2012
Figure 5-7
The Global Market for Parenteral Nutrition Estimated Market Share by Leading Suppliers 2012
Table 5-11
The Global Market for Parenteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2012
Figure 5-8
The Global Market for Parenteral Nutrition Estimated U.S. Market Shares for Leading Suppliers 2012
Figure 5-9
The Global Market for Parenteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers 2012
CHAPTER SIX: TOTAL MARKET SIZE AND FORECAST
Table 6-1
The Global Market for Clinical Nutrition 2008-2016
Figure 6-1
The Global Market for Clinical Nutrition 2008-2016
Table 6-2
The Global Market for Clinical Nutrition by Product Type 2008-2016
Figure 6-2
The Global Market for Clinical Nutrition by Type 2008-2016
Figure 6-3
The Global Market for Clinical Nutrition by Type 2012
Figure 6-4
The Global Market for Clinical Nutrition by Type 2016
Table 6-3
The Global Market for Clinical Nutrition by Country 2008, 2010 and 2012
Figure 6-5
The Global Market for Clinical Nutrition by Country 2008, 2010 and 2012
Table 6-4
Leading Suppliers Clinical Nutrition Revenues and Significant Segments of Participation, 2012
Figure 6-6
Leading Suppliers Clinical Nutrition Estimated Market Shares, 2012
CHAPTER SEVEN: ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET
Table 7-1
Nutrition Products with Specific Wound Management Benefits
Table 7-2
Parenteral Nutrition Shortages, updated September 2012
Table 7-3
U.S. National Breastfeeding Statistics
Figure 7-1
U.S. National Breastfeeding Statistics
Table 7-4
Medicare Reimbursement for Home Parenteral and Enteral Nutrition; DME MAC.
Table 7-5
Enteral Product Classification, 2012
Table 7-6
Example of DMEPOS Fee Schedule for Common Enteral Items, 2012 Fee Schedule
Table 7-7
Example of DMEPOS Fee Schedule for Common Parenteral Items, 2012 Fee Schedule
Table 7-8
WIC Participants by Participant Category in 2006, 2009, 2010
Figure 7-2
Distribution of WIC Participants by Type, 2006
Figure 7-3
Distribution of WIC Participants by Type, 2010
Table 7-9
WIC Agencies and Distribution of Participants by State, 2010
Table 7-10
Dieticians and Nutritionists by Facility Type, 2011
Table 7-11
Highest Number of Dieticians and Nutritionists by State, 2011
Table 7-12
Highest Concentration of Dieticians and Nutritionists by State, 2011
Table 7-13
Recalls of Infant Feeding Products, 2001-2012
Table 7-14
Selected Enteral Feeding Pumps

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.